A new study from the Harvey L. Neiman Health Policy Institute found that only 1.8% of eligible Americans with commercial insurance received lung cancer screening. Rates were higher but still extremely low for Original Medicare (3.4%) and Medicare Advantage (4.6%). The study, published in the Journal of the American College of Radiology, determined 2017 screening rates for patients who were eligible for lung cancer screening by low-dose computed tomography (LDCT), as determined United States Preventive Services Task Force guidelines.
Tag: LDCT
Lung Cancer Screening Saves Lives!
Dr. Douglas E. Wood describes the findings from the NELSON Trial and what they mean for policy and program development for lung cancer early detection through CT screening.